Clinical operations field note

Clinical Operations Planning After a Biotech Partnership

Define sponsor responsibilities, handoffs, staffing, and governance before a biotech partnership adds new clinical trial work.

By Lampgen Clinical Research

1 min read · estimated

WHO WILL EXECUTE THE PROGRAM AFTER THE DEAL?

A licensing or development partnership creates scientific and financial opportunity.

It also creates an operating handoff.

Teams may need to align:

• decision rights and governance • sponsor and partner responsibilities • CRO and vendor relationships • systems and documentation • protocol and development assumptions • reporting and escalation pathways

If the partnership adds studies, geographies, or milestones, the existing Clinical Operations team may inherit more coordination before additional capacity is approved.

The workforce question belongs inside integration planning: who owns each activity, where does oversight sit, and what capability is missing?

Lampgen provides flexible oncology CTM and CRA support for organizations navigating program growth and transition.

AVAILABLE FOR NEW PARTNERSHIPS

What does your clinical team need next?